Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-07-23 Goddard Glenn Senior Vice President, Finance Exercise or conversion +5,681 $31.64 $180K 7,000
2015-07-23 Goddard Glenn Senior Vice President, Finance Sale −7,000 $120.45 $843K 0
2015-07-23 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −1,319 94,779
2015-07-23 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −5,681 89,098
2015-07-20 Biller Scott Chief Scientific Officer Exercise or conversion +5,500 $31.64 $174K 39,570
2015-07-20 Biller Scott Chief Scientific Officer Sale −5,500 $113.87 $626K 34,070
2015-07-20 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,500 301,880
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion +909 $0.69 $625 909
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion +7,273 $2.34 $17K 8,182
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion +3,725 $9.05 $34K 11,907
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion +1,093 $23.10 $25K 13,000
2015-07-17 Goddard Glenn Senior Vice President, Finance Sale −13,000 $113.71 $1.5M 0
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −909 108,189
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −7,273 100,916
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −3,725 97,191
2015-07-17 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −1,093 96,098
2015-07-16 Cantley Lewis Clayton Jr. Director Sale −2,426 $114.17 $277K 157,558
2015-07-16 Cantley Lewis Clayton Jr. Director Sale −2,426 $114.20 $277K 157,558
2015-07-16 Higgons John Duncan Chief Operating Officer Exercise or conversion +8,264 $0.30 $2K 130,099
2015-07-16 Higgons John Duncan Chief Operating Officer Exercise or conversion +11,736 $0.30 $4K 141,835

Page 88 of 93 · 1,853 trades